XML 27 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Common stock, beginning balance (in shares) at Dec. 31, 2019     1,197          
Treasury stock, beginning balance (in shares) at Dec. 31, 2019       (429)        
Beginning balance at Dec. 31, 2019 $ 12,805 $ (3) $ 0 $ (5,563) $ 11,174 $ 7,813 $ (3) $ (619)
Components of comprehensive income:                
Net income 2,197         2,197    
Other comprehensive income (loss) (3)             (3)
Issuance of common stock pursuant to employee stock options (in shares)     5          
Issuance of common stock pursuant to employee stock options 171       171      
Issuance of common stock pursuant to restricted stock units (in shares)     1          
Issuance of common stock pursuant to restricted stock units 0              
Restricted stock surrendered for employees’ tax liability (40)       (40)      
Share-based compensation expense related to employee stock options and restricted stock units 226       226      
Dividends (316)         (316)    
Common stock, ending balance (in shares) at Dec. 31, 2020     1,203          
Treasury stock, ending balance (in shares) at Dec. 31, 2020       (429)        
Ending balance at Dec. 31, 2020 15,037   $ 0 $ (5,563) 11,531 9,691   (622)
Components of comprehensive income:                
Net income 2,699         2,699    
Other comprehensive income (loss) 44             44
Issuance of common stock pursuant to employee stock options (in shares)     2          
Issuance of common stock pursuant to employee stock options 90       90      
Issuance of common stock pursuant to restricted stock units (in shares)     6          
Issuance of common stock pursuant to restricted stock units 0              
Restricted stock surrendered for employees' tax liability (in shares)     (3)          
Restricted stock surrendered for employees’ tax liability (245)       (245)      
Share-based compensation expense related to employee stock options and restricted stock units 339       339      
Dividends (365)         (365)    
Common stock, ending balance (in shares) at Dec. 31, 2021     1,208          
Treasury stock, ending balance (in shares) at Dec. 31, 2021       (429)        
Ending balance at Dec. 31, 2021 17,599   $ 0 $ (5,563) 11,715 12,025   (578)
Components of comprehensive income:                
Net income 1,513         1,513    
Other comprehensive income (loss) (47)             (47)
Issuance of common stock pursuant to employee stock options (in shares)     1          
Issuance of common stock pursuant to employee stock options 47       47      
Issuance of common stock pursuant to restricted stock units (in shares)     7          
Issuance of common stock pursuant to restricted stock units 0              
Restricted stock surrendered for employees' tax liability (in shares)     (3)          
Restricted stock surrendered for employees’ tax liability (227)       (227)      
Settlement of liability-classified awards in restricted stock units 204       204      
Share-based compensation expense related to employee stock options and restricted stock units 521       521      
Dividends (367)         (367)    
Common stock, ending balance (in shares) at Dec. 31, 2022     1,213          
Treasury stock, ending balance (in shares) at Dec. 31, 2022       (429)        
Ending balance at Dec. 31, 2022 $ 19,243   $ 0 $ (5,563) $ 12,260 $ 13,171   $ (625)